Interestingly, CENPF and FOXM1 were predicted to be master regulators of prostate cancer malignancy in a cross-species computational analysis by comparing interactomes of human and mice (7), and experimental validation demonstrated that they function synergistically to promote tumor growth by regulating prostate cancer-associated target gene expression profiles. This evidence concerns the gene CENPF and prostate carcinoma.